GELS (Gelteq) Long-Term Debt: $0.01 Mil (As of Dec. 2025)


GELS Gelteq Ltd GELS
8 GF Score
Price $0.59
! 4 Warning Signs
View Full Analysis

What is Gelteq Long-Term Debt?

Gelteq GELS -3.36% 8 Long-Term Debt is $0.01 Mil as of Dec. 2025. GuruFocus rates GELS with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Gelteq's Long-Term Debt for the quarter that ended in Dec. 2025 was $0.01 Mil.

Gelteq's quarterly Long-Term Debt stayed the same from Dec. 2024 ($0.01 Mil) to Jun. 2025 ($0.01 Mil) and stayed the same from Jun. 2025 ($0.01 Mil) to Dec. 2025 ($0.01 Mil).

Gelteq's annual Long-Term Debt declined from Jun. 2023 ($1.66 Mil) to Jun. 2024 ($1.17 Mil) and declined from Jun. 2024 ($1.17 Mil) to Jun. 2025 ($0.01 Mil).

Gelteq  (NAS:GELS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gelteq Long-Term Debt Related Terms

Gelteq Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gelteq's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Long-Term Debt Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial 0.13 1.03 1.66 1.17 0.01

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 0.00 1.17 0.01 0.01 0.01
GELS
8GF Score
Gelteq Ltd GELS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.01 Mil mean?
Gelteq (GELS) has a Long-Term Debt of $0.01 Mil as of Dec. 2025.
Is Gelteq's Long-Term Debt too high?
Gelteq's current Long-Term Debt is $0.01 Mil. Overall, Gelteq has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Long-Term Debt compare to YCBD and AKAN?
Gelteq's Long-Term Debt of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gelteq's current Long-Term Debt is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Long-Term Debt of $0.01 Mil. The current Long-Term Debt is $0.01 Mil. Gelteq's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gelteq (GELS), the current Long-Term Debt is $0.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
8GF Score

Get the complete analysis for GELS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price